2-氨基-5-(4-甲氧基苯基))-1,3,4-噻二唑 | 1014-25-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-氨基-5-(4-甲氧基苯基))-1,3,4-噻二唑
• 中文别名: 2-氨基-5-(4-甲氧基苯基)-1,3,4-噻二唑
• 英文名称: 5-(4-methoxy-phenyl)-[1,3,4]thiadiazol-2-ylamine
• 英文别名: 5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-amine；2-amino-5-(4-methoxyphenyl)-1,3,4-thiadiazole；2-Amino-5-(4-methoxyphenyl)-1,3,4-thiadiazol
• CAS: 1014-25-1
• 化学式: C₉H₉N₃OS
• mdl: MFCD00813220
• 分子量: 207.256
• InChiKey: UJBCFMCQLVRXBQ-UHFFFAOYSA-N

物化性质

• 熔点：
  185-187 °C
• 沸点：
  393.1±44.0 °C(Predicted)
• 密度：
  1.320±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  89.3
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2934999090
• 安全说明：
  S26,S36
• 危险标志：
  GHS07
• 危险性描述：
  H315,H319,H335
• 危险性防范说明：
  P261,P305 + P351 + P338
• 储存条件：
  存储条件为2-8°C，避光，并需保存在惰性气体环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-5-(4-methoxyphenyl)-1,3,4-thiadiazole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-(4-methoxyphenyl)-1,3,4-thiadiazole
CAS number: 1014-25-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H9N3OS
Molecular weight: 207.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-5-(4-甲氧基苯基))-1,3,4-噻二唑 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 3.0h， 生成 [1,3]Dithiolan-2-ylidene-[5-(4-methoxy-phenyl)-[1,3,4]thiadiazol-2-yl]-amine
  参考文献：
  名称：

  Tiwari, Shailendra, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2018, p. 1416 - 1420

  摘要：

  DOI：
• 作为产物：
  描述：

  4-methoxybenzylidene thiosemicarbazone 在 三氯化铁 作用下， 以 水 为溶剂， 反应 0.75h， 以60%的产率得到2-氨基-5-(4-甲氧基苯基))-1,3,4-噻二唑
  参考文献：
  名称：

  一些新型的3- [5-取代的1,3,4-噻二唑-2-基] -2-苯乙烯基喹唑啉-4（3H）-的合成及CNS抑制活性。

  摘要：

  合成了一系列新型的3- [5-取代苯基-1,3,4-噻二唑-2-基] -2-苯乙烯基喹唑啉-4（3H）-并评估其抗惊厥，镇静催眠和中枢神经系统抑制活性。在以30、100和300mg / kg体重腹腔注射小鼠后，在最大电击诱发癫痫发作（MES）和皮下戊四氮（scPTZ）诱发的癫痫发作模型中检查了2-苯乙烯基喹唑啉-4（3H）-衍生物。老鼠。使用转子法评估神经毒性。在18种化合物中，只有4a，4d，4e，4j和4k在一个或多个测试模型中显示出抗惊厥活性。通过光度计屏幕，除4e和4f外，所有其他药物均显示出明显的镇静催眠活性。借助于强制游泳池法筛选的中枢神经系统抑制剂活性产生了一些有效的化合物。

  DOI：

  10.1016/j.ejmech.2007.02.004

文献信息

• Synthesis, antibacterial and antifungal activity of some novel 3-[5-(4-substituted phenyl) 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones
  作者：Varsha Jatav、Sushil Kashaw、Pradeep Mishra

  DOI：10.1007/s00044-007-9047-2

  日期：2008.6

  3-[5-substituted phenyl-1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones were synthesized and evaluated for antibacterial activity against pathogenic strains of Staphylococcus aureus (MTCC no. 96), Bacillus subtilis (MTCC no. 619), Pseudomonas aeruginosa (MTCC no. 424) and Escherichia coli (MTCC no. 40) and antifungal activity against Aspergillus niger, Candida albicans and Fusarium oxysporum

  合成了一系列新型的3- [5-取代的苯基-1,3,4-噻二唑-2-基] -2-苯乙烯基喹唑啉-4（3H）-，并评估了其对 金黄色葡萄球菌 致病菌株的抗菌活性 （ MTCC编号96）， 枯草芽孢杆菌 （MTCC编号619）， 铜绿假单胞菌 （MTCC编号424）和 大肠杆菌 （MTCC编号40）以及对 黑曲霉，白色念珠菌 和 尖孢镰刀菌的 抗真菌活性 。采用杯板法测定化合物的最小抑菌浓度（MIC）值。一些化合物表现出与诺氟沙星相当的活性。本报告揭示了合成的2-苯乙烯基-喹唑啉-4（3H）-一具有比抗真菌活性更好的抗菌作用。
• Synthesis and evaluation of the trypanocidal activity of a series of 1,3,4-thiadiazoles derivatives of R-(+)-limonene benzaldehyde-thiosemicarbazones
  作者：Solange C. Martins、Vânia C. Desoti、Danielle Lazarin-Bidóia、Fábio Vandresen、Cleuza C. da Silva、Tania Ueda-Nakamura、Sueli de O. Silva、Celso V. Nakamura

  DOI：10.1007/s00044-016-1561-7

  日期：2016.6

  selectivity indexes. The vast majority of the monoterpene derivatives, substituted by R-(+)-limonene, presented better anti-T. cruzi activity than the non-substituted compounds. Regarding the cytotoxic profile, the compounds without the monoterpene R-(+)-limonene were, in general, less toxic. The present findings indicate that the 1,3,4-thiadiazoles derivatives of R-limonene have potential trypanocidal activity

  在这项研究中，我们合成了一系列R -（+）-mon烯苯甲醛-硫代半咔唑酮（2a - k）的1,3,4-噻二唑衍生物。我们还确定了LLCMK 2细胞的细胞毒性以及克氏锥虫，这些合成化合物以及一系列不含单萜R -（+）-柠檬烯（4a的1,3,4-噻二唑– k）。1,3,4-噻二唑化合物显示出显着的锥虫杀灭活性和高选择性指数。被R -（+）-柠檬烯取代的绝大多数单萜衍生物表现出更好的抗T.活性高于非取代化合物。关于细胞毒性特征，通常不含单萜R -（+）-柠檬烯的化合物毒性较小。目前的发现表明，R-柠檬烯的1,3,4-噻二唑衍生物具有潜在的锥虫杀虫活性，因此有必要进行进一步的研究以更好地了解这些物质对克氏锥虫的作用机理。
• PhI-Catalyzed Intramolecular Oxidative Coupling Toward Synthesis of 2-Amino-1,3,4-Thiadizoles
  作者：Yingzhi Han、Yadong Sun、Ablimit Abdukader、Bifu Liu、Duozhi Wang

  DOI：10.1007/s10562-018-2541-y

  日期：2018.11

  derivatives via intramolecular oxidative coupling of thiosemicarbazide, using the in situ generated hypervalent iodine(III) reagents is developed. The protocol can be carried out smoothly and provides a variety of thiadiazole derivatives in moderate to excellent yields.Graphical AbstractA highly efficient method for the synthesis of thiadiazole derivatives via PhI-catalyzed intramolecular oxidative coupling

  摘要 开发了一种利用原位生成的高价碘（III）试剂，通过氨基硫脲的分子内氧化偶联合成噻二唑衍生物的高效方法。该协议可以顺利进行，并以中等至优异的收率提供各种噻二唑衍生物。图形摘要一种高效的合成噻二唑衍生物的方法通过 PhI 催化分子内氧化偶联氨基硫脲。
• Synthesis and Biological Evaluation of Novel Carbazole Hybrids as Promising Antimicrobial Agents
  作者：Mahamadhanif S. Shaikh、Balakumar Chandrasekaran、Mahesh B. Palkar、Ashish M. Kanhed、Afsana Kajee、Koleka P. Mlisana、Parvesh Singh、Meenu Ghai、Mavela Cleopus Mahlalela、Rajshekhar Karpoormath

  DOI：10.1002/cbdv.201900550

  日期：2020.5

  of series 1 displayed notable antimicrobial activity (MIC: 6.25 μg/mL) against clinical isolates of C. albicans and C. neoformans (MIC: 12.5 μg/mL). From the second series, four compounds exhibited significant antifungal and antibacterial activity, especially against C. neoformans and S. aureus. The most active compound of series 2 displayed a prominent antimicrobial activity against C. neoformans

  8-甲氧基-N-取代-9H-咔唑-3-甲酰胺（系列1）和咔唑基取代的若丹宁（系列2）的两个系列咔唑类似物通过简便的合成路线合成。评估了这两个系列的所有最终化合物对四种真菌（白色念珠菌、新型隐球菌、热带隐球菌和黑曲霉）和四种细菌（金黄色葡萄球菌、枯草芽孢杆菌、大肠杆菌和铜绿假单胞菌）的初步体外抗真菌和抗菌活性) 应变，分别。在测试的化合物中，系列 1 的三种化合物显示出有希望的抗真菌和抗菌活性，尤其是对新型隐球菌和金黄色葡萄球菌。此外，系列 1 的一种化合物显示出显着的抗微生物活性（MIC：6.25 μg/mL），对临床分离株 C. 白色念珠菌和新型隐球菌（MIC：12.5 μg/mL）。在第二个系列中，四种化合物表现出显着的抗真菌和抗菌活性，尤其是对新型隐球菌和金黄色葡萄球菌。系列 2 中活性最强的化合物分别显示出对新型隐球菌（MIC：3.125 μg/mL）和金黄色葡萄球菌（MIC：1.56
• [EN] NITROGEN-CONTAINING HETEROARYL DERIVATIVES<br/>[FR] DÉRIVÉS HÉTÉROARYLIQUES CONTENANT DE L'AZOTE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011089132A1

  公开（公告）日：2011-07-28

  The invention is concerned with novel nitrogen-containing heteroaryl derivatives of formula (I) wherein R1, R2, R3, R4, R5, A1, A2, and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.

  本发明涉及式(I)的新氮杂芳基衍生物，其中R1、R2、R3、R4、R5、A1、A2和Y的定义如描述和权利要求中所述，以及这些化合物的生理可接受的盐和酯。这些化合物可以抑制PDE10A，并可作为药物使用。